In order to maintain stable and homeostatic glycemic levels (below 1.4 g/l 1.5 hours after a meal), T1D patients require subcutaneous injections of insulin while individuals suffering from T2D take oral medications to improve insulin sensitivity, in some cases supplemented with insulin injections. This evidence concerns the gene INS and type 1 diabetes mellitus.